Prostate Cancer in the Era of COVID-19
The programme is designed to offer an expert opinion exchange and provide some practical approaches for management of Prostate Cancer during the COVID-19 pandemic.
Prostate Cancer in the Era of COVID-19
Chair: Silke Gillessen
Speakers: Ursula Vogl, Thomas Powles
*The ESMO Webinar Series is freely available to all healthcare professionals working in Oncology
Programme
- Introduction, Silke Gillessen Sommer, MD, Istituto Oncologico della Svizzera Italiana (IOSI), Bellinzona, Switzerland
- Clinical case presentation, Ursula Vogl, MD, Istituto Oncologico della Svizzera Italiana (IOSI), Bellinzona, Switzerland
- Management of prostate cancer according to the recent ESMO COVID-19 recommendations, Silke Gillessen Sommer, MD, Istituto Oncologico della Svizzera Italiana (IOSI), Bellinzona, Switzerland
- Discussion, Silke Gillessen Sommer, MD, Istituto Oncologico della Svizzera Italiana (IOSI), Bellinzona, Switzerland, Ursula Vogl, MD, Istituto Oncologico della Svizzera Italiana (IOSI), Bellinzona, Switzerland, Thomas Powles, MD, MRCP, MBBS, Barts Cancer Institute, London, UK
- Closing Remarks, Silke Gillessen Sommer, MD, Istituto Oncologico della Svizzera Italiana (IOSI), Bellinzona, Switzerland
Learning objectives
- Understand the impact of the COVID-19 pandemic in the management of prostate cancer patients
- Review the recent ESMO adapted recommendations on prostate cancer in the COVID-19 era
- Present a case of prostate cancer patient
- Discuss the case of prostate cancer patient under the guidance of a moderator senior expert, author of the ESMO COVID-19 recommendations assisted with the speakers’ panel
*The ESMO Webinar Series is freely available to all healthcare professionals working in Oncology
